These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1101761

  • 1. Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.
    Tally FP, Louie TJ, Weinstein WM, Bartlett JG, Gorbach SL.
    Ann Intern Med; 1975 Oct; 83(4):484-8. PubMed ID: 1101761
    [Abstract] [Full Text] [Related]

  • 2. Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms.
    Tally FP, Louie TJ, O'Keefe P, Gorbach SL, Bartlett JG.
    J Infect Dis; 1976 Nov; 134 SUPPL():S428-32. PubMed ID: 993634
    [Abstract] [Full Text] [Related]

  • 3. Amikacin therapy for serious gram-negative infection.
    Pollock AA, Berger SA, Richmond AS, Simberkoff MS, Rahal JJ.
    JAMA; 1977 Feb 07; 237(6):562-4. PubMed ID: 576282
    [Abstract] [Full Text] [Related]

  • 4. Amikacin therapy of severe infections produced by gram-negative bacilli resistant to gentamicin.
    Valdivieso M, Bodey GP.
    Am J Med Sci; 1977 Feb 07; 273(2):177-84. PubMed ID: 860733
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
    Maslow MJ, Simberkoff MS, Rahal JJ.
    J Antimicrob Chemother; 1985 Aug 07; 16(2):227-34. PubMed ID: 3934125
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E, Schoutens E, Vanderlinden MP.
    Chemotherapy; 1975 Aug 07; 21(1):45-51. PubMed ID: 807457
    [Abstract] [Full Text] [Related]

  • 7. Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use.
    Levine JF, Maslow MJ, Leibowitz RE, Pollock AA, Hanna BA, Schaefler S, Simberkoff MS, Rahal JJ.
    J Infect Dis; 1985 Feb 07; 151(2):295-300. PubMed ID: 3918124
    [Abstract] [Full Text] [Related]

  • 8. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM, McGee ZA, Alford RH.
    Arch Intern Med; 1978 Feb 07; 138(2):201-5. PubMed ID: 415674
    [Abstract] [Full Text] [Related]

  • 9. Amikacin in treatment of infections caused by gram-negative bacteria resistant to gentamicin and other aminoglycosides: clinical and bacteriologic results.
    Daikos GK, Kosmidis JC, Hamilton-Miller JM, Brumfitt W.
    J Infect Dis; 1976 Nov 07; 134 SUPPL():S286-90. PubMed ID: 993623
    [Abstract] [Full Text] [Related]

  • 10. Amikacin for treatment of infections in patients with malignant diseases.
    Bodey GP, Rodriguez V, Valdivieso M, Feld R.
    J Infect Dis; 1976 Nov 07; 134 SUPPL():S421-7. PubMed ID: 993633
    [Abstract] [Full Text] [Related]

  • 11. Amikacin Therapy of Urinary tract infections.
    Cox CE.
    J Infect Dis; 1976 Nov 07; 134 SUPPL():S362-8. PubMed ID: 792358
    [Abstract] [Full Text] [Related]

  • 12. Controlled comparison of amikacin and gentamicin.
    Smith CR, Baughman KL, Edwards CQ, Rogers JF, Lietman PS.
    N Engl J Med; 1977 Feb 17; 296(7):349-53. PubMed ID: 319355
    [Abstract] [Full Text] [Related]

  • 13. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR, Greenman RL, Hoffman TA.
    Arch Intern Med; 1978 May 17; 138(5):713-6. PubMed ID: 348135
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Amikacin treatment of pulmonary infections involving gentamicin-resistant gram-negative bacilli.
    Bartlett JG.
    Am J Med; 1977 Jun 17; 62(6):945-8. PubMed ID: 868911
    [Abstract] [Full Text] [Related]

  • 16. Amikacin therapy of infections in neutropenic patients.
    Valdivieso M, Feld R, Rodriguez V, Bodey GP.
    Am J Med Sci; 1975 Jun 17; 270(3):453-63. PubMed ID: 1108649
    [Abstract] [Full Text] [Related]

  • 17. Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial.
    Klastersky J, Hensgens C, Meunier-Carpentier F.
    J Infect Dis; 1976 Nov 17; 134 SUPPL():S433-40. PubMed ID: 792359
    [Abstract] [Full Text] [Related]

  • 18. [Amikacin treatment of septicemia due to gentamicin-resistant gram-negative bacilli (author's transl)].
    Tomioka H, Kobayashi Y, Tamatani S, Morishita T, Hasegawa Y.
    Jpn J Antibiot; 1975 Jun 17; 28(3):305-8. PubMed ID: 807757
    [No Abstract] [Full Text] [Related]

  • 19. Amikacin therapy of gram-negative bacteremia.
    Tally FP, Gorbach SL.
    Am J Med; 1977 Jun 17; 62(6):936-9. PubMed ID: 868909
    [Abstract] [Full Text] [Related]

  • 20. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E, Di Leonardo F, Giordano G, De Felice M, Cerquetti F, Vonmoos A.
    Minerva Urol; 1981 Jun 17; 33(2):85-90. PubMed ID: 7322100
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.